LCT
Living Cell Technologies Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Living Cell Technologies Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is focused on discovering and developing treatments for conditions, such as diabetes and Parkinson's disease. The company operates in both Australia and New Zealand, being the research and development and product development into living cell technologies. The firm's product candidate includes NTCELL, an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells targeting Parkinson’s disease. Choroid plexus cells are naturally occurring support cells for the brain and secrete cerebrospinal fluid (CSF), which contains a range of factors that support nerve cell functions and protective enzymes that are crucial for nerve growth and healthy functioning. In NTCELL, the porcine choroid plexus cells are coated with LCT's technology IMMUPEL to protect them from attack by the immune system. The firm has completed two clinical trials of NTCELL in Parkinson's disease.
📈 Performance
Price History
-77.99%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in LCT
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in LCT
961 days
LCT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
50%
100k - 150k
50k - 100k
Less than 50k
50%
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
50%
Male
50%
Pearlers who invest in LCT also invest in...
Argosy Minerals Ltd. develops and produces lithium, base metals, graphite and related minerals. The company is headquartered in Perth, Western Australia. The firm has interest in the Rincon Lithium Project in Salta Province, Argentina. The company also has an interest in the Tonopah Lithium Project in Nevada, United States. The Rincon Lithium Project comprises up to approximately 2,794 hectares of Mining Titles and mining easement landholdings at the Salar del Rincon in Salta Province, Argentina. The Project is located in the elevated and arid Puna region of Argentina and forms part of a number of highly mineralized salars in production and development. The Company’s Tonopah Lithium Project is located within the Big Smokey Valley region in Nevada, United States, and comprises 425 claims covering an area of 34.25 square kilometers (km2). The Tonopah Lithium Project is directly analogous to the neighboring Silver Peak Lithium Mine deposit model, both geologically and structurally.
📊 Share price
$0.47 AUD
Bionomics Ltd. is a clinical stage biopharmaceutical company. The firm is focused on developing allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with unmet medical needs. The firm operates in the drug development segment in Australia. The firm is advancing its lead drug candidate, BNC210, which is an oral, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). Its α7 Receptor Positive Allosteric Modulators (PAMs) pipeline is targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. The company also includes a pre-clinical CNS pipeline that has two earlier-stage small molecule discovery programs targeting ion channels and representing opportunities for clinical programs.
📊 Share price
$0.02 AUD
GBM Resources Ltd. is an exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-10-24. The firm has a project portfolio, hosting district scale mineral systems, located in a number of premier metallogenic terrains. Its projects include Mount Coolon Gold Project, Yandan Gold Project, Twin Hills Gold Project, White Dam Project, and Nippon Mining of Australia Copper Joint Venture Projects. The Mount Coolon Gold Project is located within the Drummond Basin and is located approximately 250 kilometers (km) to the West of Mackay in North Queensland. The tenement package covers a total area of over 2,613 square kilometers. The Yandan Project is located approximately 40 km to the west of the township of Mount Coolon and 155 km southeast of Charters Towers, north Queensland. Its tenure covers an area of approximately 952 square kilometers.
📊 Share price
$0.02 AUD
Alara Resources Ltd. operates as a minerals exploration company. The company is headquartered in Balcatta, Western Australia. The company went IPO on 2007-05-24. The firm is primarily focused on the exploration, evaluation and development of mineral licenses in Oman. Its Al Hadeetha Copper-Gold Project is located approximately 80-160 kilometers east and southeast of Alara's Daris Copper-Gold Project and Awtad Copper-Gold Project. Its Al Hadeetha Copper-Gold Project comprises over three exploration licenses (Washihi-Mazzaza, Mullaq and Al Ajal) and one mining license (Washihi-Mazzaza) covering a total area of approximately 80 square kilometers. The Company’s Daris Copper-Gold Project is located approximately 150 kilometers west of Muscat, the capital of Oman. The Daris Copper-Gold Project comprises one exploration license (Block 7) of approximately 587 square kilometers, located adjacent (contiguous) to another Alara Project, the Awtad Copper-Gold Project.
📊 Share price
$0.03 AUD
Want more shares? Try these...
Legacy Iron Ore Ltd. engages in the exploration and development of iron ore, gold, and base metal deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2008-07-08. The firm is focused on the development of iron ore, gold and base metal deposits. Its Legacy Iron’s South Laverton Project includes the Mt Celia, Yerilla, Yilgangi, Sunrise Bore and Patricia North tenements. Its Mt Celia Project lies within the Laverton Tectonic Zone, some 40 kilometers (km) south of the Sunrise Dam gold mine. Its Yilgangi Project includes two exploration tenements (E31/1019 and E31/1020) and two mining leases (M31/426 and M31/427). Its Sunrise Bore project lies some 12 km east of the world-class Sunrise Dam gold mine operated by Anglo Gold Ashanti. The Patricia North Project lies in and adjacent to a major deformation zone that hosts significant gold mineralization. The firm operates the Mt Bevan Joint Venture in the Yilgarn of Western Australia. The firm also holds exploration license E80/4122 which is contiguous with ground under exploration by Anglo Australian Resources Limited.
📊 Share price
